An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Rockley Photonics to Present at Upcoming Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Rockley Photonics Holdings Limited (NYSE: RKLY), a medical technology company specializing in silicon photonics-based biosensing solutions, announced its participation in two upcoming investor conferences:
Bernstein 2nd Annual CGM Disruptors Conference on November 18, 2022, at 11:05 a.m. ET.
BTIG Digital Health Forum Panel on November 21, 2022, at 11:00 a.m. ET.
Live webcasts will be available on the company’s investor relations page.
Positive
None.
Negative
None.
OXFORD, England & PASADENA, Calif.--(BUSINESS WIRE)--
Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it will participate in the following investor conferences.
- Bernstein 2nd Annual CGM Disruptors Conference on Friday, November 18, 2022, at 11:05 a.m. ET
- BTIG Digital Health Forum Panel on Monday, November 21, 2022, at 11:00 a.m. ET
For access to the conferences, please contact your representatives at Bernstein and BTIG. When available, a live webcast and replay of the presentation will be accessible from the investor relations page of the Rockley Photonics Holdings Limited website at https://investors.rockleyphotonics.com.
About Rockley Photonics
Formed in 2013, Rockley is a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions that target a portfolio of biomarkers. Rockley's ground-breaking end-to-end biosensing platform unlocks unique spectra-based biomarkers enabling insights into personal health and well-being. With next-generation biosensing platforms specifically designed for mobile health monitoring, Rockley is laying the foundation for a new generation of biomedical applications across multiple industries.
What are the dates for Rockley Photonics' investor conferences?
Rockley Photonics will participate in the Bernstein 2nd Annual CGM Disruptors Conference on November 18, 2022, and the BTIG Digital Health Forum Panel on November 21, 2022.
What time will Rockley Photonics present at these conferences?
Rockley Photonics will present at 11:05 a.m. ET on November 18, 2022, and at 11:00 a.m. ET on November 21, 2022.
Where can I access the live webcasts of Rockley Photonics' presentations?
Live webcasts of Rockley Photonics' presentations will be accessible from their investor relations page on their website.
What is Rockley Photonics focused on?
Rockley Photonics focuses on delivering silicon photonics-based biosensing solutions, targeting a portfolio of biomarkers for health monitoring.
